Clinical trial · Interventional
Bioavailability of Legume Proteins in Differents Products
Single-blind, Randomized, Cross-over Comparative Bioavailability Study About the Kinetics of Plasma Amino Acid Concentrations Subsequent to the Consumption of Innovative Legume-based Products.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The use of pea proteins could be interesting in specific foods. Indeed, these proteins could have great nutritional quality, with good amino acid profile. Therefore, the investigators study the bioavailability of protein and post-prandial variation of metabolic markers following consumption of pea protein-enriched products in healthy young subjects. Main Objective is to compare plasma kinetics of leucine.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy | — | UNRESOLVED | — |
| Men | Multiple Endocrine Neoplasia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| amino acids kinetics | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- type
- EXPERIMENTAL
- label
- Chocolate cake with peas
- description
- the subjects will consume the test meals (arm title)
- interventionNames
- Other: amino acids kinetics
- type
- EXPERIMENTAL
- label
- Biscuit with peas
- description
- the subjects will consume the test meals (arm title).
- interventionNames
- Other: amino acids kinetics
- type
- EXPERIMENTAL
- label
- chopped steack with peas
- description
- the subjects will consume the test meals (arm title).
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * Major male volunteers under 30 (\<30) * Body mass index between 22 and 28 kg/m² * Subjects considered healthy by investigator based on the examination, medical and clinical examination, * biological check up considered compatible with study participation * person who is in the position to sign informed consent Exclusion Criteria: * Subject with a particular diet (vegetarians, vegans, nutritional supplements, etc.), * Subject weight \< 60 kg * Subject refusing to consume one of the proposed products or the test meal * Subject with a food allergy(s) to one or more components of the study products (gluten, legumes, etc.), or with a contribution to the consumption of these products. * Subject with tumor pathology, inflammatory, moderate to severe kidney failure, malabsorption syndrome, * Subject being under drug treatment or dietary supplement that may influence the results of kinetics: treatments that may affect gastric emptying, intestinal absorption (smectite-based intestinal dressings, etc.), insulin and blood sugar, Oral nutritional supplements (NOC), proton pump inhibitors (PPIs), corticosteroids, nonsteroidal anti-inflammatory drugs, antibiotics for less than a month, * Subject with diabetes or dyslipidemia, * Subject with a heavy medical or surgical history that may pose a risk to the volunteer under the protocol, * Subject who has undergone surgery that may interfere with the objectives of the study (at the discretion of the investigating physician) within 3 months preceding the study, * Person refusing to be registered on the National File of Healthy Volunteers of the Ministry of Health, * Major subject under trusteeship or with limited rights, * Subject not affiliated with social security, * Subject during the exclusion period of a previous study (after verification in the Biomedical Research Volunteers File).
References
Publications (0)
Data not yet available